Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients

BACKGROUND: Increasing evidence shows that alterations in gut microbiome (GM) contribute to the development of type 2 diabetes mellitus (T2DM), and fecal microbiota transplantation (FMT) successfully treats various human diseases. However, the benefits of FMT therapy to T2DM patients remain unknown....

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Dafa, Yong, Huijuan, You, Na, Lu, Wei, Yang, Xu, Ye, Xiaolong, Wang, Yayun, Cai, Tingting, Zheng, Xiaoling, Chen, Hui, Cui, Bota, Zhang, Faming, Liu, Xingyin, Mao, Jian-Hua, Lu, Yibing, Chang, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990819/
https://www.ncbi.nlm.nih.gov/pubmed/35402293
http://dx.doi.org/10.3389/fcimb.2022.820367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990819/
https://www.ncbi.nlm.nih.gov/pubmed/35402293
http://dx.doi.org/10.3389/fcimb.2022.820367

Ejemplares similares